For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Cohort 1 | This cohort received starting dose of 250 ug/tumor injection once a week | 0 | None | 0 | 2 | 2 | 2 | View |
| Cohort 2 | This cohort received 500 ug/tumor injection once a week | 0 | None | 0 | 1 | 1 | 1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Skin hypopigmentation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE (4.3) | View |
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | CTCAE (4.3) | View |
| Lymphocyte Count Decrease | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE (4.3) | View |
| White blood cell decrease | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE (4.3) | View |
| Blood bilirubin increase | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE (4.3) | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE (4.3) | View |
| Squamous Cell Carcinoma | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE (4.3) | View |
| Actinic Keratosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE (4.3) | View |